fagaronine has been researched along with Leukemia L 1210 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Al-Khara, S; Charpentier, E; Devy, J; Duval, O; Helesbeux, JJ; Letinois, I; Martiny, L; Ouchani, F; Oudot, C; Rabenoelina, F; Salesse, S; Vanquelef, E | 1 |
Bisagni, E; Croisy, A; Janin, YL; Riou, JF | 1 |
2 other study(ies) available for fagaronine and Leukemia L 1210
Article | Year |
---|---|
The anti-invasive activity of synthetic alkaloid ethoxyfagaronine on L1210 leukemia cells is mediated by down-regulation of plasminogen activators and MT1-MMP expression and activity.
Topics: Alkaloids; Animals; Aprotinin; Benzophenanthridines; Cell Death; Cell Proliferation; Dipeptides; Down-Regulation; Enzyme Activation; Fibrinolysin; Gelatinases; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Leukemia L1210; Matrix Metalloproteinase 14; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Neoplasm Invasiveness; Plasminogen Activators | 2011 |
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives.
Topics: Adenocarcinoma; Alkaloids; Animals; Antineoplastic Agents; Benzophenanthridines; Breast Neoplasms; Humans; Leukemia L1210; Leukemia P388; Mice; Molecular Structure; Phenanthridines; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1993 |